BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36858069)

  • 1. Continuous Glucose Monitoring and Time in Range: Association with Adverse Outcomes among People with Type 2 or Gestational Diabetes Mellitus.
    Bitar G; Cornthwaite JA; Sadek S; Ghorayeb T; Daye N; Nazeer S; Ghafir D; Cornthwaite J; Chauhan SP; Sibai BM; Fishel Bartal M
    Am J Perinatol; 2024 May; 41(S 01):e1370-e1377. PubMed ID: 36858069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time in Range and Pregnancy Outcomes in People with Diabetes Using Continuous Glucose Monitoring.
    Fishel Bartal M; Ashby Cornthwaite JA; Ghafir D; Ward C; Ortiz G; Louis A; Cornthwaite J; Chauhan SSP; Sibai BM
    Am J Perinatol; 2023 Apr; 40(5):461-466. PubMed ID: 35858653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrete glucose profiles identified using continuous glucose monitoring data and their association with adverse pregnancy outcomes.
    Battarbee AN; Sauer SM; Sanusi A; Fulcher I
    Am J Obstet Gynecol; 2024 Jul; 231(1):122.e1-122.e9. PubMed ID: 38527606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Moy FM; Ray A; Buckley BS; West HM
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009613. PubMed ID: 28602020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Continuous Glucose Monitoring Metrics With Pregnancy Outcomes in Patients With Preexisting Diabetes.
    Sanusi AA; Xue Y; McIlwraith C; Howard H; Brocato BE; Casey B; Szychowski JM; Battarbee AN
    Diabetes Care; 2024 Jan; 47(1):89-96. PubMed ID: 37782847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring in individuals undergoing gestational diabetes screening.
    Fishel Bartal M; Ashby Cornthwaite J; Ghafir D; Ward C; Nazeer SA; Blackwell SC; Pedroza C; Chauhan SP; Sibai BM
    Am J Obstet Gynecol; 2023 Oct; 229(4):441.e1-441.e14. PubMed ID: 37088275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial.
    Voormolen DN; DeVries JH; Sanson RME; Heringa MP; de Valk HW; Kok M; van Loon AJ; Hoogenberg K; Bekedam DJ; Brouwer TCB; Porath M; Erdtsieck RJ; NijBijvank B; Kip H; van der Heijden OWH; Elving LD; Hermsen BB; Potter van Loon BJ; Rijnders RJP; Jansen HJ; Langenveld J; Akerboom BMC; Kiewiet RM; Naaktgeboren CA; Mol BWJ; Franx A; Evers IM
    Diabetes Obes Metab; 2018 Aug; 20(8):1894-1902. PubMed ID: 29603547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal visit utilization and outcomes in pregnant women with type II and gestational diabetes.
    Carter EB; Tuuli MG; Odibo AO; Macones GA; Cahill AG
    J Perinatol; 2017 Feb; 37(2):122-126. PubMed ID: 27735930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
    Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study.
    Yu F; Lv L; Liang Z; Wang Y; Wen J; Lin X; Zhou Y; Mai C; Niu J
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4674-82. PubMed ID: 25057872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Jones LV; Ray A; Moy FM; Buckley BS
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detemir vs neutral protamine Hagedorn insulin for diabetes mellitus in pregnancy: a comparative effectiveness, randomized controlled trial.
    Fishel Bartal M; Ward C; Blackwell SC; Ashby Cornthwaite JA; Zhang C; Refuerzo JS; Pedroza C; Lee KH; Chauhan SP; Sibai BM
    Am J Obstet Gynecol; 2021 Jul; 225(1):87.e1-87.e10. PubMed ID: 33865836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Moy FM; Ray A; Buckley BS
    Cochrane Database Syst Rev; 2014 Apr; (4):CD009613. PubMed ID: 24782359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The timing of initiation of pharmacotherapy for women with gestational diabetes mellitus.
    Harrison RK; Cruz M; Wong A; Davitt C; Palatnik A
    BMC Pregnancy Childbirth; 2020 Dec; 20(1):773. PubMed ID: 33308193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different methods and settings for glucose monitoring for gestational diabetes during pregnancy.
    Raman P; Shepherd E; Dowswell T; Middleton P; Crowther CA
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011069. PubMed ID: 29081069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: A post-hoc analysis of the GlucoMOMS trial.
    Rademaker D; van der Wel AWT; van Eekelen R; Voormolen DN; de Valk HW; Evers IM; Mol BW; Franx A; Siegelaar SE; van Rijn BB; DeVries JH; Painter RC;
    Diabetes Obes Metab; 2023 Dec; 25(12):3798-3806. PubMed ID: 37735847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes.
    McLean A; Barr E; Tabuai G; Murphy HR; Maple-Brown L
    Diabetes Technol Ther; 2023 Dec; 25(12):836-844. PubMed ID: 37902969
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters.
    Murphy HR
    Diabetologia; 2019 Jul; 62(7):1123-1128. PubMed ID: 31161344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.